Borregaard ASA (BRG.OL)
ValueMarkers Composite Index
9% above intrinsic value ($16)
Borregaard ASA (BRG.OL) — VMCI valuation read
BRG.OL prints VMCI 63/100 inside the broad-market sample, where the median sits at 50. The 13-point above-median delta is the cleanest single-number summary of Borregaard ASA's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On BRG.OL, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** BRG.OL trades at 22.0x earnings, 22% above the sector median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the sector median (10.0%); that is the quality line. net debt to EBITDA of -1.5x leaves covenant headroom; that is the risk line for Borregaard ASA on the trailing financials.
BRG.OL rose 0.5% over the trailing 7 days, with a +1.6% read on a 30-day basis.
Borregaard ASA develops, produces, and markets specialized biomaterials, biochemicals, and biofuels in Norway, rest of Europe, the United States, Asia, and internationally. It operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for a range of applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and bioethanol. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Related Stocks
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.